Evaluación positiva de medicamentos: marzo y abril 2018 / Possitive assesment of drugs: March and April 2018
Sanid. mil
; 74(3): 163-167, jul.-sept. 2018.
Article
in Es
| IBECS
| ID: ibc-182294
Responsible library:
ES1.1
Localization: BNCS
RESUMEN
Se reseñan los medicamentos evaluados y con dictamen positivo por comisión de expertos de la Agencia Española de Medicamentos y Productos Sanitarios o de la Agencia Europea del Medicamento publicados en marzo y abril de 2018, considerados de mayor interés para el profesional sanitario. Se trata de opiniones técnicas positivas que son previas a la autorización y puesta en el mercado del medicamento
ABSTRACT
The drugs assessed by the Spanish Agency for Medicines and Health Products or European Medicines Agency made public in March, April and May of 2018, and considered of interest to the healthcare profesional, are reviewed. These are positive technical reports prior to the authorization and placing on the market of the product
Full text:
1
Collection:
06-national
/
ES
Database:
IBECS
Main subject:
Treatment Outcome
/
Drug Evaluation
Limits:
Humans
Language:
Es
Journal:
Sanid. mil
Year:
2018
Document type:
Article